Zurex Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.zurex-pharma.com
Perioperative Patient Skin Antiseptic Preparation Evaluation
Phase 3
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Drug: 70% v/v Isopropyl Alcohol Surgical Solution
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT04756804
- Locations
- 🇺🇸
MCW/FH, Milwaukee, Wisconsin, United States
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
Phase 3
Completed
- Conditions
- Surgical Skin Preparation
- Interventions
- Drug: ZuraPrep VehicleDrug: ChloraPrepDrug: ZuraPrep Clear Solution
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT03782103
- Locations
- 🇺🇸
Microbac Laboratories, Inc., Sterling, Virginia, United States
In-vivo Efficacy of Patient Preoperative Prep
Phase 3
Completed
- Conditions
- Surgical Skin Preparation
- Interventions
- Drug: ZP VehicleDrug: ZuraPrepDrug: ChloraPrep
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 440
- Registration Number
- NCT02831998
- Locations
- 🇺🇸
MicroBioTest Laboratories, Sterling, Virginia, United States
Clinical Evaluation of Patient Preoperative Prep
Phase 3
Completed
- Conditions
- Surgical Skin Preparation
- Interventions
- Drug: ZuraPrepDrug: ZP VehicleDrug: ChloraPrep
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2021-07-16
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 640
- Registration Number
- NCT02831816
- Locations
- 🇺🇸
BioScience Laboratories, Inc., Bozeman, Montana, United States
Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle
Phase 3
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Drug: ZuraPrep with 70% IPADrug: ZuraPrep without 70% IPADrug: ChloraPrep CHG/IPA Teal TintOther: Normal Saline
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT02578771
- Locations
- 🇺🇸
MicroBioTest, Sterling, Virginia, United States
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)
Phase 2
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Drug: ChloraPrepDrug: ZuraPrep
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT02296645
- Locations
- 🇺🇸
MicroBioTest Laboratories, Sterling, Virginia, United States
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™
Phase 2
Terminated
- Conditions
- Surgical Site Infection
- Interventions
- Drug: ZuraPrepDrug: ZuraPrep VehicleDrug: Chloraprep
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2016-07-18
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT02221232
- Locations
- 🇺🇸
BioSciences Laboratories, Inc., Bozeman, Montana, United States
Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
Phase 1
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Drug: ChloraprepDrug: 0.9% Physiological SalineOther: ZuraPrep without IPA
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 208
- Registration Number
- NCT02160587
- Locations
- 🇺🇸
BioScience Laboratories, Inc., Bozeman, Montana, United States
Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
Phase 1
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Drug: ChloraPrepDrug: 0.1% Sodium Lauryl SulfateDrug: 0.9% Physiological SalineOther: ZuraPrep without IPA
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2014-10-27
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02160574
- Locations
- 🇺🇸
BioScience Laboratories, Bozeman, Montana, United States
© Copyright 2025. All Rights Reserved by MedPath